Search research articles
Contact Us
Filters
Showing results (81-90 of 380) with videos related to
Page
of 38
Sort By:
Future Oncology (London, England)
|
September 13, 2024
Logistical challenges of CAR T-cell therapy in non-Hodgkin lymphoma: a survey of healthcare professionals
Anna Sureda, Shiraz El Adam, Shibing Yang, et al.
American Journal of Hematology
|
June 25, 2010
XPC genetic polymorphisms correlate with the response to imatinib treatment in patients with chronic phase chronic myeloid leukemia
Vicent M Guillem, Francisco Cervantes, Jesús Martínez, et al.
Journal of Clinical Apheresis
|
September 12, 2016
Prospective noninterventional study on peripheral blood stem cell mobilization in patients with relapsed lymphomas
Gwendolyn van Gorkom, Herve Finel, Sebastian Giebel, et al.
Transplantation and Cellular Therapy
|
September 21, 2020
Impact of Reduced-Intensity Conditioning Regimens on Outcomes in Diffuse Large B Cell Lymphoma Undergoing Allogeneic Transplantation
Narendranath Epperla, Kwang W Ahn, Manoj Khanal, et al.
Haematologica
|
January 26, 2006
Chemotherapy-induced nausea and vomiting in acute leukemia and stem cell transplant patients: results of a multicenter, observational study
Javier López-Jiménez, Eva Martín-Ballesteros, Anna Sureda, et al.
Leukemia & Lymphoma
|
February 2, 2012
Efficacy, safety and quality-of-life associated with lenalidomide plus dexamethasone for the treatment of relapsed or refractory multiple myeloma: the Spanish experience
Adrian Alegre, Albert Oriol-Rocafiguera, Jose Garcia-Larana, et al.
Cytotherapy
|
January 21, 2018
Handling, processing and disposal of stem cell products in Europe: A survey by the cellular therapy and immunobiology working party of the European Society for Blood and Marrow Transplantation
Andreas Holbro, Helen Baldomero, Francesco Lanza, et al.
Cancer
|
July 31, 2009
Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis
Alois Gratwohl, Martin Stern, Ronald Brand, et al.
The Lancet. Haematology
|
November 29, 2023
CD19-directed CAR T cells as first salvage therapy for large B-cell lymphoma: towards a rational approach
Peter Dreger, Paolo Corradini, John G Gribben, et al.
Ejhaem
|
July 18, 2022
Liquid biopsy for disease monitoring after anti-CD19 chimeric antigen receptor T cell in diffuse large B-cell lymphoma
Clara Maluquer, Beatriz Bellosillo, Alberto Mussetti, et al.
Page
of 38
Search research articles
Search
Showing results (81-90 of 380) with videos related to
Sort By:
Page
of 38
Future Oncology (London, England)
|
September 13, 2024
Logistical challenges of CAR T-cell therapy in non-Hodgkin lymphoma: a survey of healthcare professionals
Anna Sureda, Shiraz El Adam, Shibing Yang, et al.
American Journal of Hematology
|
June 25, 2010
XPC genetic polymorphisms correlate with the response to imatinib treatment in patients with chronic phase chronic myeloid leukemia
Vicent M Guillem, Francisco Cervantes, Jesús Martínez, et al.
Journal of Clinical Apheresis
|
September 12, 2016
Prospective noninterventional study on peripheral blood stem cell mobilization in patients with relapsed lymphomas
Gwendolyn van Gorkom, Herve Finel, Sebastian Giebel, et al.
Transplantation and Cellular Therapy
|
September 21, 2020
Impact of Reduced-Intensity Conditioning Regimens on Outcomes in Diffuse Large B Cell Lymphoma Undergoing Allogeneic Transplantation
Narendranath Epperla, Kwang W Ahn, Manoj Khanal, et al.
Haematologica
|
January 26, 2006
Chemotherapy-induced nausea and vomiting in acute leukemia and stem cell transplant patients: results of a multicenter, observational study
Javier López-Jiménez, Eva Martín-Ballesteros, Anna Sureda, et al.
Leukemia & Lymphoma
|
February 2, 2012
Efficacy, safety and quality-of-life associated with lenalidomide plus dexamethasone for the treatment of relapsed or refractory multiple myeloma: the Spanish experience
Adrian Alegre, Albert Oriol-Rocafiguera, Jose Garcia-Larana, et al.
Cytotherapy
|
January 21, 2018
Handling, processing and disposal of stem cell products in Europe: A survey by the cellular therapy and immunobiology working party of the European Society for Blood and Marrow Transplantation
Andreas Holbro, Helen Baldomero, Francesco Lanza, et al.
Cancer
|
July 31, 2009
Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis
Alois Gratwohl, Martin Stern, Ronald Brand, et al.
The Lancet. Haematology
|
November 29, 2023
CD19-directed CAR T cells as first salvage therapy for large B-cell lymphoma: towards a rational approach
Peter Dreger, Paolo Corradini, John G Gribben, et al.
Ejhaem
|
July 18, 2022
Liquid biopsy for disease monitoring after anti-CD19 chimeric antigen receptor T cell in diffuse large B-cell lymphoma
Clara Maluquer, Beatriz Bellosillo, Alberto Mussetti, et al.
Page
of 38